Michael Martin, MD, MBA, affiliated with Takeda Pharmaceuticals USA, Inc. in Lexington, Massachusetts, has published research focusing on Attention-Deficit/Hyperactivity Disorder (ADHD) within child and adolescent psychiatry, as well as adult ADHD during the COVID-19 pandemic. His work includes studies on caregiver experiences managing ADHD in youth and the experiences of adults with ADHD amid the pandemic. His research contributions between 2023 and 2024 have appeared in Psychiatrist.com.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
